Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

American Journal of Gastroenterology

Volumn 100, Issue 11, 2005, Pages 2438-2446

  Musso, Giovanni ^a,c   Gambino, Roberto ^a   Biroli, Giampaolo ^a   Carello, Monica ^a   Fagà, Emanuela ^a   Pacini, Giovanni ^b   De Michieli, Franco ^a   Cassader, Maurizio ^a   Durazzo, Marilena ^a   Rizzetto, Mario ^a   Pagano, Gianfranco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CNR   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOADIPONECTINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MALE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK FACTOR; ADAPTATION; BLOOD; BODY MASS; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; FATTY LIVER; FEEDING BEHAVIOR; FORECASTING; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; LIVER CIRRHOSIS; MEDICAL RECORD; METABOLISM; NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ADIPONECTIN; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; FOOD HABITS; FORECASTING; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIVER CIRRHOSIS; MALE; MEDICAL RECORDS; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644636469     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00297.x     Document Type: Article

References (45)

1. Clark JM Brancati FL Diehl AME. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003 98 : 960 67.
2. Clark JM Diehl A. MBFL. Nonalcoholic fatty liver disease and the risk of type 2 diabetes in the United States. Diabetes 2001 50 : A38 ( abstract).
3. Vozarova B Stefan N Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002 51 : 1889 95.
4. Sattar N Scherbakova O Ford I, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 2004 53 : 2855 60.
5. Angulo P Keach JC Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999 30 : 1356 62.
6. El-Serag HB Tran T Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004 126 : 460 8.
7. Younossi ZM Gramlich T Mattoni CA, et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004 2 : 262 5.
8. Pagano G Pacini G Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002 35 : 367 72.
9. Kahn SE. The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001 86 : 4047 58.
10. Weyer C Tataranni PA Bogardus C, et al. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2000 24 : 89 94.
11. Greenberg AS McDaniel ML. Identifying the links between obesity, insulin resistance and β-cell function: Potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 2002 32 ( suppl 3 24 34.
12. Fumeron F Aubert A Siddiq A, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period. The epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004 53 : 1150 7.
13. Hui JM Hodge A Farrell GC, et al. Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 2004 40 : 46 54.
14. Brunt EM. Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis 2001 21 : 3 16.
15. Pisani P Faggiano F Krogh V, et al. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 1997 26 ( suppl 1 S152 60.
16. Sacerdote C Fiorini L Dalmasso M, et al. Alimentazione e rischi di cancro. Indagine su un campione di 10054 volontari residenti nell'area torinese. Torino : AGAT, 2000.
17. Carnovale E Marletta L. Food Composition Table. Milano : EDRA, Istituto Nazionale della Nutrizione, 1997.
18. Salvini S Parpinel M Gnagnarella P, et al. Banca Dati di Composizione degli Alimenti per Studi Epidemiologici in Italia. Istituto Europeo di Oncologia. Reggio Calabria: Laruffa, 1988.
19. Bergman RN Watanabe R Rebrin K, et al. Toward an integrated phenotype in pre-NIDDM. Diabet Med 1996 13 : S67 77.
20. Bergman RN Lovejoy JC ( Eds.). The Minimal Model Approach and Determinants of Glucose Tolerance. Baton Rouge, LA : LSU Press, 1997.
21. Kahn SE Prigeon RL McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 42 : 1663 72.
22. Ahrén B Pacini G. Impaired adaptation of first phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol 1997 273 : E701 7.
23. Ahrén B Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 2004 150 : 97 104.
24. Executive summary of the third report of the national cholesterol education program (NCEP) export panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001 285 : 2486 97.
25. Musso G Gambino R De Michieli F, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003 37 : 909 16.
26. Clinical Practice Recommendations 2004. Diabetes Care 2004 27 : S5 10.
27. Matsuzawa Y Funahashi T Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004 24 : 29 33.
28. Kim HJ Kim HJ Lee KE, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004 164 : 2169 75.
29. Perseghin G Mazzaferro V Sereni LP, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation. Hepatology 2000 31 : 694 703.
30. Roche E Maestre I Martin F, et al. Nutrient toxicity in pancreatic beta-cell dysfunction. J Physiol Biochem 2000 56 : 119 28.
31. Maedler K Spinas GA Dyntar D, et al. Distinct effects of saturated and monounsaturated fatty acids on cell turnover and function. Diabetes 2001 50 : 69 76.
32. Ahrén B Pacini G. Signals adapting the beta cells to changes in insulin sensitivity. In : Crepaldi G Tiengo A Avogaro A, eds. The Metabolic Syndrome: Diabetes, Obesity, Hyperlipidemia & Hypertension, Excerpta Medica ICS 1253. New York : Elsevier, 2003 : 105 13.
33. Rakatxi I Mueller H Ritzeler O, et al. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 2004 47 : 249 58.
34. Matsui J Terauchi Y Kubota N, et al. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-χ-deficient mice on a high-fat diet. Diabetes 2004 53 : 2844 54.
35. Lewis GF Uffelman KD Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995 95 : 158 66.
36. Lewis GF Uffelman KD Szeto LW, et al. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals. Diabetes 1993 42 : 833 42.
37. Malmstrom R Packard CJ Caslake M, et al. Detective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 1997 40 : 454 62.
38. Seppala-Lindroos A Vehkavaara S Hakkinen AM, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002 87 : 3023 8.
39. Bajaj M Suraamornkul S Piper P, et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004 89 : 200 6.
40. Xu A Wang Y Keshaw H. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003 112 : 91 100.
41. Masaki T Chiba S Tatsukawa H, et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice. Hepatology 2004 40 : 177 84.
42. Kamada Y Tamura S Kiso S, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003 125 : 1796 807.
43. Fassio E Alvarez E Dominguez N, et al. Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies. Hepatology 2004 40 : 820 6.
44. Bays H Mandarino L DeFronzo R. Role of the adypocyte, free fatty acids, and ectopic fat in the pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004 89 : 463 78.
45. Tiikkainen M Hakkinen AM Korsheninnikova E, et al. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 2004 53 : 2169 76.